U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Advanced Non-Hodgkin Lymphoma

MedGen UID:
1750455
•Concept ID:
C5419617
•
Neoplastic Process

Definition

Non-Hodgkin lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. [from NCI]

Professional guidelines

PubMed

Who does not receive treatment for cancer?
Ward MM, Ullrich F, Matthews K, Rushton G, Goldstein MA, Bajorin DF, Hanley A, Lynch CF
J Oncol Pract 2013 Jan;9(1):20-6. doi: 10.1200/JOP.2012.000829. PMID: 23633967Free PMC Article

Recent clinical studies

Etiology

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ
J Clin Invest 2016 Sep 1;126(9):3363-76. Epub 2016 Aug 2 doi: 10.1172/JCI86721. PMID: 27482888Free PMC Article
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D
Blood 2010 Sep 9;116(10):1795-802. Epub 2010 Jun 7 doi: 10.1182/blood-2010-02-270538. PMID: 20530284
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O'Reilly RJ, Kewalramani T, Young JW, Jakubowski AA
Bone Marrow Transplant 2010 Sep;45(9):1408-16. Epub 2010 Jan 11 doi: 10.1038/bmt.2009.371. PMID: 20062091Free PMC Article
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM
Biol Blood Marrow Transplant 2008 Jul;14(7):840-6. doi: 10.1016/j.bbmt.2008.05.002. PMID: 18541205
Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma.
Lybeert ML, Meerwaldt JH, Deneve W
Int J Radiat Oncol Biol Phys 1987 Aug;13(8):1167-72. doi: 10.1016/0360-3016(87)90190-8. PMID: 3301759

Diagnosis

COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
Colombi D, Bodini FC, Morelli N, Silva M, Milanese G, Cavanna L, Michieletti E
J Infect Chemother 2021 Jan;27(1):99-102. Epub 2020 Sep 10 doi: 10.1016/j.jiac.2020.09.008. PMID: 33023821Free PMC Article
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D
Blood 2010 Sep 9;116(10):1795-802. Epub 2010 Jun 7 doi: 10.1182/blood-2010-02-270538. PMID: 20530284
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O'Reilly RJ, Kewalramani T, Young JW, Jakubowski AA
Bone Marrow Transplant 2010 Sep;45(9):1408-16. Epub 2010 Jan 11 doi: 10.1038/bmt.2009.371. PMID: 20062091Free PMC Article
Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement.
Camera A, Villa MR, Rocco S, De Novellis T, Costantini S, Pezzullo L, Lucania A, Mariano A, Macchia V, Rotoli B
Cancer 2000 Jan 1;88(1):75-8. doi: 10.1002/(sici)1097-0142(20000101)88:1<75::aid-cncr11>3.0.co;2-#. PMID: 10618608
Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma.
Dudgeon DJ, Brower M
Cancer 1993 May 1;71(9):2813-6. doi: 10.1002/1097-0142(19930501)71:9<2813::aid-cncr2820710921>3.0.co;2-d. PMID: 7682150

Therapy

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ
J Clin Invest 2016 Sep 1;126(9):3363-76. Epub 2016 Aug 2 doi: 10.1172/JCI86721. PMID: 27482888Free PMC Article
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.
Kaplan LD, Deitcher SR, Silverman JA, Morgan G
Clin Lymphoma Myeloma Leuk 2014 Feb;14(1):37-42. Epub 2013 Oct 1 doi: 10.1016/j.clml.2013.09.009. PMID: 24252360
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D
Blood 2010 Sep 9;116(10):1795-802. Epub 2010 Jun 7 doi: 10.1182/blood-2010-02-270538. PMID: 20530284
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM
Biol Blood Marrow Transplant 2008 Jul;14(7):840-6. doi: 10.1016/j.bbmt.2008.05.002. PMID: 18541205
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT, Rosenthal DS, Moloney WC, Frei E 3rd
Blood 1977 May;49(5):759-70. PMID: 66957

Prognosis

COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
Colombi D, Bodini FC, Morelli N, Silva M, Milanese G, Cavanna L, Michieletti E
J Infect Chemother 2021 Jan;27(1):99-102. Epub 2020 Sep 10 doi: 10.1016/j.jiac.2020.09.008. PMID: 33023821Free PMC Article
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ
J Clin Invest 2016 Sep 1;126(9):3363-76. Epub 2016 Aug 2 doi: 10.1172/JCI86721. PMID: 27482888Free PMC Article
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.
Kaplan LD, Deitcher SR, Silverman JA, Morgan G
Clin Lymphoma Myeloma Leuk 2014 Feb;14(1):37-42. Epub 2013 Oct 1 doi: 10.1016/j.clml.2013.09.009. PMID: 24252360
Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma.
Lybeert ML, Meerwaldt JH, Deneve W
Int J Radiat Oncol Biol Phys 1987 Aug;13(8):1167-72. doi: 10.1016/0360-3016(87)90190-8. PMID: 3301759
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT, Rosenthal DS, Moloney WC, Frei E 3rd
Blood 1977 May;49(5):759-70. PMID: 66957

Clinical prediction guides

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ
J Clin Invest 2016 Sep 1;126(9):3363-76. Epub 2016 Aug 2 doi: 10.1172/JCI86721. PMID: 27482888Free PMC Article
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.
Kaplan LD, Deitcher SR, Silverman JA, Morgan G
Clin Lymphoma Myeloma Leuk 2014 Feb;14(1):37-42. Epub 2013 Oct 1 doi: 10.1016/j.clml.2013.09.009. PMID: 24252360
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D
Blood 2010 Sep 9;116(10):1795-802. Epub 2010 Jun 7 doi: 10.1182/blood-2010-02-270538. PMID: 20530284
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O'Reilly RJ, Kewalramani T, Young JW, Jakubowski AA
Bone Marrow Transplant 2010 Sep;45(9):1408-16. Epub 2010 Jan 11 doi: 10.1038/bmt.2009.371. PMID: 20062091Free PMC Article
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM
Biol Blood Marrow Transplant 2008 Jul;14(7):840-6. doi: 10.1016/j.bbmt.2008.05.002. PMID: 18541205

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...